Flowchart vs. process map, what do you choose to use? When it comes to mapping out a project, you’ve got several choices on how to visualize them. If you’ve had trouble deciding on a format for your ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

The biotech giant is facing over 67,000 US lawsuits over allegations that its Roundup weedkiller causes cancer — a claim Bayer denies. Shares in Bayer rose over 9% during Tuesday morning trading in ...

Bayer's third-quarter sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead as generic competition and litigation liabilities bed in. Pharma ...

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Kasper Hjulmand Formation: 3 - 4 - 2 - 1 Manager: Lukas Kwasniok ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Manuel Baum Formation: 3 - 4 - 2 - 1 Manager: Kasper Hjulmand Formation: ...

New study to test Sema3A antibody in rare genetic kidney disease Evotec SE has announced that partner Bayer AG has initiated a phase 2 clinical study of BAY 3401016, a monoclonal antibody targeting ...

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

Shares of Bayer BAYN1.37%increase; green up pointing triangle rose as much as 14% on Tuesday after the U.S. Solicitor General supported the company’s push for the Supreme Court to take up its Roundup ...

Investing.com -- Bayer shares jumped on Monday after President Donald Trump’s administration urged the U.S. Supreme Court to take up the company’s bid to limit thousands of lawsuits alleging that ...

Trump administration supports Bayer's Supreme Court appeal Bayer faces over 67,000 lawsuits over Roundup's alleged cancer risk Solicitor General says juries should not second-guess EPA's science-based ...